The Synthetic Biology Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Increasing R&D in Biotechnological and Pharmaceutical Businesses
The growing demand for synthetic biology in biotechnological and pharmaceutical research and development leads to the growth of this industry. For example, the pharmaceutical research-based business spends about 149.8 billion USD each year on R&D, according to the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). Organisms and engineered networks for disease-mechanism elucidation, drug-discovery platforms, drug-target identification, therapeutic delivery, therapeutic treatment, and drug manufacture are examples of synthetic biology contributions to the field of therapeutic. The synthetic biology industry is likely to increase significantly in the near future due to rising demand for medicinal applications.Environment Safety Challenges May Restrict The Adoption of Synthetic Biology Up to Certain Extent
The deliberate or unintentional introduction of synthetic organisms into the environment during research and other applications poses a significant biosafety issue in synthetic biology. Synthetic bacteria can mutate or interact with other species in the environment, leading in crossbreeding and bio errors. This has the potential to threaten the environment of wild creatures. The emergence of antibiotic-resistant superbugs is another key biosafety worry. In recent years, the European Union (EU) has funded a number of research studies investigating the environmental impact of genetically modified bacteria purposely released for plant growth or bioremediation. However, biosafety, biosecurity, and ethical risks associated with synthetic biology may stymie business growth.What Questions Should You Ask before Buying a Market Research Report?
- How is the synthetic biology market evolving?
- What is driving and restraining the synthetic biology market?
- How will each synthetic biology submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
- How will the market shares for each synthetic biology submarket develop from 2022 to 2032?
- What will be the main driver for the overall market from 2022 to 2032?
- Will leading synthetic biology markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
- Who are the leading players and what are their prospects over the forecast period?
- What are the synthetic biology projects for these leading companies?
- How will the industry evolve during the period between 2020 and 2032? What are the implications of synthetic biology projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the synthetic biology market?
- Where is the synthetic biology market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the synthetic biology market today, and over the next 10 years:
- Our 745-page report provides 355 tables and 710 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them - NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
Forecasts to 2032 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2032, the new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising synthetic biology prices and recent developments.
Segments Covered in the Report
Product Type Outlook
- Oligonucleotides & Synthetic DNA
- Enzymes
- Cloning Technology Kits
- Synthetic Cells
- Synthetic Genes
- Synthetic Clones
- Chassis Organisms
- Xeno-Nucleic Acids
- Other Product Types
Technology Outlook
- Gene Synthesis
- Genome Engineering
- Sequencing
- Bioinformatics
- Cloning
- Site-Directed Mutagenesis
- Measurement & Modeling
- Microfluidics
- Nanotechnology
- Other Technologies
Application Outlook
- Medical & Pharmaceutical Applications
- Drug Discovery and Therapeutics (Cancer Detection & Diagnostics, Other Drug Discovery and Therapeutic Applications)
- Artificial Tissue & Tissue Regeneration (Bio-Synthesis, Stem Cell Regulation, Other Artificial Tissue and Tissue Regeneration Applications)
- Industrial Applications
- Biofuel and Renewable Energy
- Industrial Enzymes (Textile Industry, Paper Industry, Other Industries)
- Biomaterials & Green Chemicals
- Food & Agriculture
- Environmental Applications
- Bioremediation
- Biosensing
- Other Applications
Operation
- Preclinical
- Clinical
- Commercial
- Other Operations
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- South Africa
- UAE
- Egypt
- Rest of Middle East & Africa
Leading companies and the potential for market growth
- Amyris Inc.
- Agilent Technologies Inc.
- Codexis, Inc.
- Danaher Corporation
- ElevateBio
- Genscript Biotech Corporation
- Ginkgo Bioworks
- GRO Biosciences
- Merck KGaA
- New England Biolabs
- Precigen Inc.
- Synthetic Genomics (Viridos)
- Synlogic
- Twist Bioscience Corp.
- Thermo Fisher Scientific Inc.
How will the Synthetic Biology Market, 2022 to 2032 report help you?
In summary, this 740+ page report provides you with the following knowledge:- Revenue forecasts to 2032 for Synthetic Biology Market, 2022 to 2032 Market, with forecasts for product type, technology, and application, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2032 for five regional and 20 key national markets - See forecasts for the Synthetic Biology Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, South Africa, UAE and Egypt among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the Synthetic Biology Market, 2022 to 2032.
Information found nowhere else
With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the Synthetic Biology Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.Table of Contents
1 Report Overview
3 Premium Insights
4 Market Overview
5 Global Synthetic Biology Market Analysis by Product Type
6 Global Synthetic Biology Market Analysis by Technology
7 Global Synthetic Biology Market Analysis by Application
8 Global Synthetic Biology Market Analysis by Region
9 North America Synthetic Biology Market Analysis
10 Europe Synthetic Biology Market Analysis
11 Asia Pacific Synthetic Biology Market Analysis
12 Latin America Synthetic Biology Market Analysis
13 MEA Synthetic Biology Market Analysis
14 Competitive Landscape
15 Conclusion and Recommendations
List of Tables
Companies Mentioned
- Amyris Inc.
- Agilent Technologies Inc.
- Codexis, Inc.
- Danaher Corporation
- ElevateBio
- Genscript Biotech Corporation
- Ginkgo Bioworks
- GRO Biosciences
- Merck KGaA
- New England Biolabs
- Precigen Inc.
- Synthetic Genomics (Viridos)
- Synlogic
- Twist Bioscience Corp.
- Thermo Fisher Scientific Inc.
- Alexion Pharmaceuticals Inc
- Astellas Pharma Inc
- Allergan plc
- Bristol-Myers Squibb Co
- Chugai Pharmaceutical Co Ltd
- Eli Lilly and Co
- Hikma Pharmaceuticals PLC
- Johnson & Johnson
- Jiangsu Hengrui Medicine Co Ltd
- Kyowa Hakko Kirin Co Ltd
- Mitsubishi Tanabe Pharma Corp
- Perrigo Company PLC
- Pfizer Inc
- Shanghai Fosun Pharmaceutical Group Co Ltd
- Shionogi & Co Ltd
- Shire PLC
- Teva Pharmaceutical Industries Ltd
- Takeda Pharmaceutical Co Ltd
- Taisho Pharmaceutical Holdings Co Ltd
- Zoetis Inc
- Association of British Pharmaceutical Industry (ABPI)
- Department of Health and Family Welfare
- Central Drugs Standard Control Organization (CDSCO)
- Development and Reform Commission (NDRC)
- European Medicines Agency (EMA)
- European Commission
- Food and Drug Administration (US FDA)
- Indian Drug Manufacturer's Association (IDMA)
- International Society of Pharmaceutical Engineering (IPSE)
- Korea Food and Drug Administration (KFDA)
- Korea Pharmaceutical Manufacturer's Association (KPMA)
- Medicines and Healthcare Products Regulatory Agency (MHRA)
- Medicines Manufacturing Industry Partnership (MMIP)
- Ministry of Health (MOH)
- Ministry of Health, Labor and Welfare (MHLW)
- Ministry of Industry and Information Technology (MIIT)
- Pharmaceutical and Medical Devices Agency (PMDA)
- World Health Organization (WHO)